FibroGen Story

FibroGen Inc -- USA Stock  

USD 45.62  0.78  1.68%

Macroaxis does not monitor all media channels or aggregates social signals for FibroGen. But even though we do not provide professional-grade financial sentiment analysis on FibroGen Inc, we do publish noise-free headlines that can be used to derive useful patterns or even a trading strategy for FibroGen. Additionally see FibroGen Hype Analysis, FibroGen Correlation and FibroGen Performance
Insider Selling FibroGen, Inc Director Sells 567000.00 in Stock
EcoR1 Capital LLC lifted its holdings in FibroGen by 3,674.1 percent in the second quarter. EcoR1 Capital LLC now owns 1,585,457 shares of the biopharmaceutical company stock valued at 51,210,000 after acquiring an additional 1,543,448 shares during the ... Traders Brace for Comeback of Volatility FibroGen, Inc. , Frontline Ltd ... - Post Analyst

Read More...   

Story Momentum

This media report from distributed on December 7, 2017 was a factor to the next trading day price appreciation.The overall trading delta against the next closing price was 2.54% . The overall trading delta when the story was published against the current closing price is 0.22% .

Similar stores for FibroGen

KBC Group NV Decreases Holdings in Incyte Corporationnews
StockNewsTimesFull coverage
FibroGen exotic insider transaction detectednews
Filed transaction by Fibrogen Inc director. Unconventional Insider trading

Did you try this?

Run Portfolio Anywhere Now

Portfolio Anywhere

Track or share privately all of your investments from the convenience of any device
Hide  View All  NextLaunch Portfolio Anywhere


Revenue Comparative Analysis
      FibroGen Comparables 
FibroGen is currently under evaluation in revenue category among related companies. Revenue is income that a firm generates from business activities such us rendering services or selling goods to customers. It is a crucial part of business and is important item when evaluating financial statements of a company. Revenues from a firm's main business operations can be reported on the income statement as sales revenue, net sales, or simply sales, depending on the industry in which given company operates.